Process Historian Cloud Hosting Connects Multi-Site Organizations
Honeywell Process Solutions' Uniformance Cloud Historian leverages cloud technology to analyze data across multiple sites and increase uptime.
Honeywell Process Solutions’ Honeywell Connected Plant Uniformance Cloud Historian is a software-as-a-service cloud hosting solution for enterprise-wide visualization and analysis, helping customers improve asset availability and increase plant uptime. The product connects complex multi-site organizations, and makes it possible to leverage insights found at one plant across all plants.
The cloud historian collects, stores, and enables replay of historical and continuous plant and production site process data and makes it visible in the cloud in near real time. The historian combines a time-series data store, which empowers plant and enterprise staff to execute and make decisions, with a big data lake, which enables data scientists to uncover previously unknown correlations between process data and other business data in the enterprise.
Projects that previously took weeks or months can now be achieved in hours. These efficiencies, combined with the ability to use a customer’s existing tools and functions, can reduce deployment and engineering time. Additionally, the scale and performance delivered through native cloud technology can reduce enterprise information technology costs. Because Uniformance Cloud Historian is built on the Honeywell Sentience Internet of Things Platform, future value may be delivered to customers in the form of additional applications and services.
Source: Honeywell Process Solutions
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
